High throughput human plasma N-glycan analysis using DNA analyzer and multivariate analysis for biomarker discovery

Carbohydrates form the majority of organic compounds found in nature and their presence on proteins influences many important bioactivities. Therefore, glycan profiling shows potential in clinical applications. This work demonstrates the use of a high-throughput GlycanAssure™ sample preparation technology and multi-capillary DNA analyzer for the analysis of the major N-linked glycans (N-glycans) found in human plasma. The application involves two biomarker studies: (1) in profiling patients with chronic kidney disease and (2) in differentiating heart disease patients with normal controls in response to an antiplatelet drug from hypo-responders. Due to complexity of the study data, bio-statistical methods were applied to data processing. 37 N-glycan peaks were observed from separation results, with confirmed structure for most glycans. Principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) were used to build models to differentiate the patient groups. The percentages of correct classification of the models reached 95.45% for the chronic kidney disease dataset and 85.42% for the anti-platelet drug response dataset. Given that blood N-glycan profiles had been shown to reflect certain disease states, this high-throughput platform could potentially be used for the simultaneous screening of multiple glycan biomarkers, with as little as one drop of blood sample. [Display omitted] •High throughput DNA Analyzer was combined with parallel magnetic bead based sample preparation.•Highly sensitive analysis of glycan profile requires only one drop of plasma using the method developed.•Higher glycan sialylation level was found in patient plasma samples compared with control.•Glycan profiling identified chronic kidney disease with correct rates of 95.45% using plasma samples.•Glycan profiling identified 85.42% hypo-responders for anti-platelet drug response samples.